Verified factor-similar pair

IVOG vs VIOG

These two ETFs pass the same FF6 US similarity lane: US-listed equity ETFs, same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB UMD
Similarity score
87
Verified similar

Score blends exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

IVOG

Vanguard S&P Mid-Cap 400 Growth ETF
SMB UMD
Adj. R2
0.917
Rel. Sharpe
0.914
Mkt beta
1.01
AUM
US$1.5B
MER
0.10%
Valuation
115

VIOG

Vanguard S&P Small-Cap 600 Growth ETF
SMB UMD
Adj. R2
0.960
Rel. Sharpe
1.156
Mkt beta
0.98
AUM
US$894M
MER
0.10%
Valuation
115

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
IVOG
+0.47
|t|
+9.9
VIOG
+0.89
|t|
+24.8
diff -0.42
HML
IVOG
+0.03
|t|
+0.6
VIOG
+0.07
|t|
+2.1
diff -0.04
RMW
IVOG
+0.17
|t|
+3.0
VIOG
+0.17
|t|
+4.0
diff -0.01
CMA
IVOG
-0.06
|t|
-0.9
VIOG
-0.05
|t|
-1.0
diff -0.01
UMD
IVOG
+0.14
|t|
+4.4
VIOG
+0.14
|t|
+5.5
diff +0.00

Why This Pair Matches

Exposure level
85
Exposure shape
99
Mkt beta diff
0.03
Rel. Sharpe diff
0.243

This comparison focuses on measured factor exposure, not a qualitative review of each fund's portfolio-construction process. Backtested relative Sharpe is included as a secondary signal, while we continue refining a comparison metric that separates factor payoff from alpha. See methodology.

IVOG fund page VIOG fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.